Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Received: 5 May 2021
Accepted: 28 February 2022
First Online: 31 March 2022
Competing interests
: Dr. Amir reports personal fees from Genentech/Roche, Apobiologix and Sandoz, outside the submitted work. Dr. Desnoyers reports personal fees from Pfizer, outside the submitted work. All remaining authors have declared no conflicts of interest.
